JPM

309.21

0%↓

BAC

53.54

-0.02%↓

WFC

87.06

-0.23%↓

MS

163.92

+0.26%↑

AXP

360.32

-0.3%↓

JPM

309.21

0%↓

BAC

53.54

-0.02%↓

WFC

87.06

-0.23%↓

MS

163.92

+0.26%↑

AXP

360.32

-0.3%↓

JPM

309.21

0%↓

BAC

53.54

-0.02%↓

WFC

87.06

-0.23%↓

MS

163.92

+0.26%↑

AXP

360.32

-0.3%↓

JPM

309.21

0%↓

BAC

53.54

-0.02%↓

WFC

87.06

-0.23%↓

MS

163.92

+0.26%↑

AXP

360.32

-0.3%↓

JPM

309.21

0%↓

BAC

53.54

-0.02%↓

WFC

87.06

-0.23%↓

MS

163.92

+0.26%↑

AXP

360.32

-0.3%↓

Search

Trupanion Inc

Gesloten

SectorFinanciën

39.42 -0.1

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

38.96

Max

40.05

Belangrijke statistieken

By Trading Economics

Inkomsten

11M

9.4M

Verkoop

12M

354M

K/W

Sectorgemiddelde

174.04

27.54

EPS

0.22

Winstmarge

2.662

Werknemers

1,130

EBITDA

13M

18M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+42.5% upside

Dividenden

By Dow Jones

Volgende Winsten

6 nov 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-153M

1.9B

Vorige openingsprijs

39.52

Vorige sluitingsprijs

39.42

Nieuwssentiment

By Acuity

50%

50%

216 / 529 Rangschikking in Finance

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

Trupanion Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

4 nov 2025, 23:57 UTC

Winsten

Naver's Third-Quarter Earnings Rose on AI Push

4 nov 2025, 23:10 UTC

Acquisities, Fusies, Overnames

Kennedy-Wilson Gets Acquisition Proposal From CEO, Fairfax Financial

4 nov 2025, 23:48 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

4 nov 2025, 23:48 UTC

Marktinformatie

Nikkei May Fall After U.S. Tech Stock Weakness -- Market Talk

4 nov 2025, 23:37 UTC

Marktinformatie

Gold Edges Higher on Possible Technical Recovery -- Market Talk

4 nov 2025, 23:30 UTC

Winsten

Itau Unibanco 3Q Net BRL33.7B >ITUB

4 nov 2025, 23:25 UTC

Winsten

Naver 3Q Net Profit Beat FactSet-Compiled Consensus

4 nov 2025, 23:25 UTC

Winsten

Naver 3Q Net KRW734.70B Vs. Net KRW530.10B >035420.SE

4 nov 2025, 23:24 UTC

Winsten

Naver 3Q Oper Pft KRW570.60B Vs. Pft KRW525.30B >035420.SE

4 nov 2025, 23:23 UTC

Winsten

Naver 3Q Rev KRW3.138T Vs. KRW2.716T >035420.SE

4 nov 2025, 23:06 UTC

Winsten

Review & Preview: Tech Check -- Barrons.com

4 nov 2025, 22:52 UTC

Winsten

AMD Reports Sharply Higher Profits, Sales -- 3rd Update

4 nov 2025, 22:33 UTC

Winsten

AMD Beats Earnings. The Stock Still Slides. -- Barrons.com

4 nov 2025, 22:29 UTC

Winsten

Ashland 4Q Adj EPS $1.08 >ASH

4 nov 2025, 22:29 UTC

Winsten

Ashland Sees FY26 Adjusted EPS Up More Than Double Digits >ASH

4 nov 2025, 22:28 UTC

Winsten

Ashland Sees FY26 Sales $1.84B-$1.91B >ASH

4 nov 2025, 22:27 UTC

Winsten

Ashland 4Q Cont Ops EPS 73c >ASH

4 nov 2025, 22:27 UTC

Winsten

Ashland 4Q EPS 71c >ASH

4 nov 2025, 22:27 UTC

Winsten

Ashland 4Q Sales $478M >ASH

4 nov 2025, 22:23 UTC

Winsten

Ovintiv 3Q EPS 57c >OVV

4 nov 2025, 22:19 UTC

Marktinformatie

Canada Budget: Snap Election Talk Might Cool -- Market Talk

4 nov 2025, 22:16 UTC

Winsten

AMD Reports Sharply Higher Profits, Sales -- 2nd Update

4 nov 2025, 22:14 UTC

Acquisities, Fusies, Overnames

Kennedy-Wilson Board Forms Special Committee to Evaluate Proposal

4 nov 2025, 22:13 UTC

Acquisities, Fusies, Overnames

Consortium: Not Interested in Selling Kennedy-Wilson Shares to Another Party

4 nov 2025, 22:13 UTC

Acquisities, Fusies, Overnames

Consortium: Able to Finance a Deal With Available Liquidity

4 nov 2025, 22:12 UTC

Acquisities, Fusies, Overnames

Consortium Owns About 31% of Kennedy-Wilson Stock on As-Converted Basis

4 nov 2025, 22:11 UTC

Winsten

Private-Credit Earnings Ease Investor Concern Over Market's Health -- Update

4 nov 2025, 22:11 UTC

Acquisities, Fusies, Overnames

Kennedy-Wilson Gets Proposal From CEO William McMorrow and Fairfax Financial Holdings

4 nov 2025, 22:10 UTC

Acquisities, Fusies, Overnames

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup -- 2nd Update

4 nov 2025, 22:07 UTC

Winsten

Kinross Gold Raises Dividend to $0.035 >K.T

Peer Vergelijking

Prijswijziging

Trupanion Inc Prognose

Koersdoel

By TipRanks

42.5% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 56.5 USD  42.5%

Hoogste 67 USD

Laagste 45 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Trupanion Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

5 ratings

3

Buy

2

Hold

0

Sell

Technische score

By Trading Central

36.22 / 44.56Steun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Strong Bullish Evidence

Lange Termijn

Neutral Evidence

Sentiment

By Acuity

216 / 529 Rangschikking in Financiën

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Trupanion Inc

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.
help-icon Live chat